Want to inform investors similar to Berwind Private Equity about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Berwind Private Equity News
Mar 4, 2019
MacuLogix, Inc. , a Harrisburg, PA-based company equipping eye care professionals with tools to diagnose and treat patients with age-related macular degeneration (AMD), completed a $38.7m Series D financing. The round was led by new investor Vivo Capital with participation from existing investors Fisk Ventures, Roche Venture Fund, Berwind Private Equity and Life Sciences Greenhouse of Central Pennsylvania. With this round of funding, Jack B. Nielsen, Managing Director of Vivo Capital, Nathan Dau, Principal of Vivo Capital, and Carole Nuechterlein, Head of Roche Venture Fund will join the MacuLogix Board of Directors. The company, which has raised a total of $51m in venture funding plus $10m in venture debt to date, intends to use the funds to accelerate domestic and international sales through expansion of workforce and infrastructure. Led by William D. McPhee, President and CEO, and Gregory R. Jackson, Ph.D., Chief Technology Officer, MacuLogix provides eye care professionals with the AdaptDx dark adaptometer, which enables eye care professionals to detect, monitor and treat AMD three years before it can be seen clinically. The company also provides in-practice training and treatment best practices to support the implementation and optimization of the AdaptDx. FinSMEs 04/03/2019
Berwind Private Equity Investments
Berwind Private Equity has made 4 investments. Their latest investment was in MacuLogix as part of their Series D on January 1, 2019.
Berwind Private Equity Investments Activity
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.